Polypoidal Choroidal Vasculopathy Diagnosis and Neovascular Activity Evaluation Using Optical Coherence Tomography Angiography.
Aged
Aged, 80 and over
Choroidal Neovascularization
/ diagnostic imaging
Diagnosis, Differential
Diagnostic Errors
Female
Fluorescein Angiography
/ methods
Humans
Macular Degeneration
/ diagnostic imaging
Male
Retrospective Studies
Tomography, Optical Coherence
/ methods
Wet Macular Degeneration
/ diagnostic imaging
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2021
2021
Historique:
received:
11
07
2021
accepted:
05
11
2021
entrez:
26
11
2021
pubmed:
27
11
2021
medline:
19
1
2022
Statut:
epublish
Résumé
To examine choroidal neovascularization (CNV) characteristics in patients with exudative age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV), using swept-source optical coherence tomography angiography (SS-OCTA), and investigate agreement with OCT B-scan, fundus fluorescein angiography (FFA), and indocyanine green angiography (ICGA) by two different examiners. This is a retrospective multicentric study that involved patients with a history of AMD and PCV. A total of 27 patients (11 females (40.7%) and 16 males (59.3%), SS-OCTA alone remains limited in some specific phenotypes of PCV, which suggests the ongoing role of B-scan OCT associated with FFA and ICGA in the diagnosis of these conditions.
Identifiants
pubmed: 34825001
doi: 10.1155/2021/1637377
pmc: PMC8610682
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1637377Informations de copyright
Copyright © 2021 Georges Azar et al.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest.
Références
Neoplasia. 2000 Jan-Apr;2(1-2):9-25
pubmed: 10933065
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT526-32
pubmed: 27472276
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT324-30
pubmed: 27409489
Clin Exp Ophthalmol. 2015 Dec;43(9):815-9
pubmed: 26183457
Retina. 2020 Dec;40(12):2296-2303
pubmed: 31971919
Sci Rep. 2019 Jan 24;9(1):595
pubmed: 30679701
Ophthalmology. 2018 May;125(5):708-724
pubmed: 29331556
Retina. 2019 Sep;39(9):1655-1663
pubmed: 29927796
Retina. 2019 Jul;39(7):1343-1352
pubmed: 29561386
Invest Ophthalmol Vis Sci. 2015 May;56(5):3187-95
pubmed: 26024102
Br J Ophthalmol. 2016 Nov;100(11):1489-1493
pubmed: 26837506
Retina. 2015 Nov;35(11):2219-28
pubmed: 26398697
Am J Ophthalmol. 2016 Apr;164:80-8
pubmed: 26851725
Retina. 2015 Nov;35(11):2265-74
pubmed: 26405770
Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):913-921
pubmed: 28233061
Retina. 2019 Sep;39(9):1693-1700
pubmed: 29965937
Retina. 2018 Jun;38(6):1187-1194
pubmed: 28613216
Indian J Ophthalmol. 2018 Dec;66(12):1727-1735
pubmed: 30451173
Retina. 2017 Aug;37(8):1464-1474
pubmed: 27828911
JAMA Ophthalmol. 2017 Dec 1;135(12):1310-1316
pubmed: 29049501
Br J Ophthalmol. 2019 Sep;103(9):1342-1346
pubmed: 30467129
Br J Ophthalmol. 2014 Nov;98(11):1528-33
pubmed: 24997181